Healthcare provider profile · identity verified

Marie E Gerow, MD

Family Practice · AUSTINTOWN, OH · NPI 1588152532

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	603	185
Lisinopril	Lisinopril	468	140
Levothyroxine Sodium	Levothyroxine Sodium	456	122
Amlodipine Besylate	Amlodipine Besylate	451	135
Metoprolol Succinate	Metoprolol Succinate	296	85
Albuterol Sulfate Hfa	Albuterol Sulfate	254	88
Omeprazole	Omeprazole	237	86
Gabapentin	Gabapentin	228	64
Rosuvastatin Calcium	Rosuvastatin Calcium	209	68
Pantoprazole Sodium	Pantoprazole Sodium	177	54
Metformin Hcl	Metformin Hcl	176	49
Hydrochlorothiazide	Hydrochlorothiazide	173	62
Losartan Potassium	Losartan Potassium	157	47
Eliquis	Apixaban	150	33
Fluticasone Propionate	Fluticasone Propionate	130	46
Duloxetine Hcl	Duloxetine Hcl	118	38
Potassium Chloride	Potassium Chloride	118	43
Furosemide	Furosemide	117	45
Jardiance	Empagliflozin	111	36
Prednisone	Prednisone	110	80
Escitalopram Oxalate	Escitalopram Oxalate	107	32
Metoprolol Tartrate	Metoprolol Tartrate	107	35
Montelukast Sodium	Montelukast Sodium	104	31
Buspirone Hcl	Buspirone Hcl	94	36
Simvastatin	Simvastatin	93	27
Azithromycin	Azithromycin	87	72
Valsartan	Valsartan	84	27
Spironolactone	Spironolactone	83	27
Famotidine	Famotidine	82	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	82	25
Metformin Hcl Er	Metformin Hcl	81	28
Bupropion Xl	Bupropion Hcl	76	27
Alendronate Sodium	Alendronate Sodium	72	25
Donepezil Hcl	Donepezil Hcl	71	15
Synthroid	Levothyroxine Sodium	71	18
Citalopram Hbr	Citalopram Hydrobromide	69	20
Trazodone Hcl	Trazodone Hcl	68	22
Allopurinol	Allopurinol	66	18
Clopidogrel	Clopidogrel Bisulfate	63	18
Ozempic	Semaglutide	63	14
Pravastatin Sodium	Pravastatin Sodium	62	18
Sertraline Hcl	Sertraline Hcl	62	19
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	59	16
Fluoxetine Hcl	Fluoxetine Hcl	57	20
Meloxicam	Meloxicam	57	20
Diclofenac Sodium	Diclofenac Sodium	55	20
Ezetimibe	Ezetimibe	55	22
Trulicity	Dulaglutide	53	12
Januvia	Sitagliptin Phosphate	51	11
Glipizide	Glipizide	49	18
Carvedilol	Carvedilol	48	12
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	48	14
Oxybutynin Chloride Er	Oxybutynin Chloride	47	14
Ketoconazole	Ketoconazole	43	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	41	12
Ibuprofen	Ibuprofen	41	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	40	20
Doxycycline Hyclate	Doxycycline Hyclate	40	32
Tizanidine Hcl	Tizanidine Hcl	40	16
Benazepril Hcl	Benazepril Hcl	39	suppressed
Glipizide Er	Glipizide	39	suppressed
Pregabalin	Pregabalin	39	14
Hydralazine Hcl	Hydralazine Hcl	38	suppressed
Mirtazapine	Mirtazapine	38	12
Sucralfate	Sucralfate	38	15
Triamcinolone Acetonide	Triamcinolone Acetonide	37	28
Celecoxib	Celecoxib	36	suppressed
Ondansetron Hcl	Ondansetron Hcl	35	21
Venlafaxine Hcl Er	Venlafaxine Hcl	35	11
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	34	29
Lidocaine	Lidocaine	34	suppressed
Meclizine Hcl	Meclizine Hcl	34	15
Olmesartan Medoxomil	Olmesartan Medoxomil	34	12
Nystatin	Nystatin	33	15
Atenolol	Atenolol	32	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	32	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	32	11
Cephalexin	Cephalexin	31	17
Xarelto	Rivaroxaban	31	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	30	suppressed
Tamsulosin Hcl	Tamsulosin Hcl	30	suppressed
Paroxetine Hcl	Paroxetine Hcl	29	suppressed
Tramadol Hcl	Tramadol Hcl	29	14
Sumatriptan Succinate	Sumatriptan Succinate	27	suppressed
Symbicort	Budesonide/Formoterol Fumarate	27	suppressed
Fenofibrate	Fenofibrate	26	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	26	12
Baclofen	Baclofen	25	suppressed
Enalapril Maleate	Enalapril Maleate	25	suppressed
Hydroxyzine Pamoate	Hydroxyzine Pamoate	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	25	21
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Mounjaro	Tirzepatide	24	suppressed
Bumetanide	Bumetanide	23	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	22	11
Chlorthalidone	Chlorthalidone	22	suppressed
Fluconazole	Fluconazole	21	19
Memantine Hcl	Memantine Hcl	21	suppressed
Ventolin Hfa	Albuterol Sulfate	21	suppressed
Lansoprazole	Lansoprazole	20	suppressed
Valacyclovir	Valacyclovir Hcl	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Breyna	Budesonide/Formoterol Fumarate	18	suppressed
Labetalol Hcl	Labetalol Hcl	18	suppressed
Olmesartan-Hydrochlorothiazide	Olmesartan/Hydrochlorothiazide	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Azelastine Hcl	Azelastine Hcl	17	suppressed
Lovastatin	Lovastatin	17	suppressed
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	17	suppressed
Amoxicillin	Amoxicillin	16	suppressed
Methylprednisolone	Methylprednisolone	16	15
Pyridostigmine Bromide	Pyridostigmine Bromide	16	suppressed
Shingrix	Varicella-Zoster Ge/As01b/Pf	16	11
Breo Ellipta	Fluticasone/Vilanterol	15	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	15	suppressed
Mupirocin	Mupirocin	15	14
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	15	suppressed
Naproxen	Naproxen	15	suppressed
Propranolol Hcl Er	Propranolol Hcl	15	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	14	suppressed
Clonazepam	Clonazepam	14	suppressed
Irbesartan	Irbesartan	14	suppressed
Metoclopramide Hcl	Metoclopramide Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Bupropion Hcl Sr	Bupropion Hcl	13	suppressed
Fosinopril Sodium	Fosinopril Sodium	13	suppressed
Glimepiride	Glimepiride	13	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	13	suppressed
Metronidazole	Metronidazole	13	11
Ropinirole Hcl	Ropinirole Hcl	13	suppressed
Varenicline Tartrate	Varenicline Tartrate	13	suppressed
Vyvanse	Lisdexamfetamine Dimesylate	13	suppressed
Clonidine	Clonidine	12	suppressed
Desipramine Hcl	Desipramine Hcl	12	suppressed
Farxiga	Dapagliflozin Propanediol	12	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Propranolol Hcl	Propranolol Hcl	12	suppressed
Amlodipine Besylate-Benazepril	Amlodipine Besylate/Benazepril	11	suppressed
Cholestyramine	Cholestyramine (With Sugar)	11	suppressed
Clindamycin Phosphate	Clindamycin Phosphate	11	suppressed
Estradiol	Estradiol	11	suppressed
Humulin R	Insulin Regular, Human	11	suppressed
Ondansetron Odt	Ondansetron	11	suppressed
Spiriva Handihaler	Tiotropium Bromide	11	suppressed
Temazepam	Temazepam	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error